Gilead (GILD) is planning to invest $11B in the U.S. to bolster its domestic manufacturing and research, Reuters reports. The investments will supplement $21B in U.S. manufacturing and R&D through 2030, according to the report. Gilead will invest in new technology, build three new facilities and upgrade three existing sites, Reuters says.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GILD:
- Gilead announces new Livdelzi data at EASL
- Gilead announces final results from MYR301 study
- Gilead put volume heavy and directionally bearish
- Gilead Sciences: Hold Rating Maintained Amid Near-Term Challenges and Limited Growth Prospects
- U.S. attorney announces $202M settlement with Gilead over kickbacks